Analysis of gut microbiota variations in patients with Henoch-Schönlein purpura: a comprehensive systematic review
- PMID: 39976893
- DOI: 10.1007/s11255-025-04406-4
Analysis of gut microbiota variations in patients with Henoch-Schönlein purpura: a comprehensive systematic review
Abstract
Objective: The primary purpose of our study was to perform a comprehensive systematic review, aiming to bring out the association between gut microbiota, Henoch-Schönlein Purpura (HSP) and Henoch-Schönlein nephritis (HSPN) patients.
Methods: A systematic review was performed using five electronic databases, including Medline (through PubMed), Scopus, Embase, Cochrane, and Web of Science, from inspection up to March 21, 2024, to detect the studies that assessed the gut microbiota variation in Henoch-Schönlein Purpura (HSP) and Henoch-Schönlein nephritis (HSPN) patients.
Results: Microbial diversity, richness, and composition in HSP patients are decreased compared to the healthy control group. In addition, HSP patients display a different microbiota structure and show a significant difference in taxonomic abundance between HSP and health control, which differs from one level to another. At the phylum level, Bacteroidetes, Fusobacteria, and Blastocladiomycota were more abundant; at the class level, Bacteroidetes were more abundant; at the order level, Bacteroidetes were more abundant in the HSP group-stage and site of HSP involvement effect on microbiota. Gastrointestinal tract involvement is characterized by increased abundance of Streptococcus and Fusobacteria and a decrease in Faecalibacterium. Kidney involvement is characterized by increased abundance of Streptococcus spp, which can be used as an indicator of disease severity. Escherichia-Shigella can be used as a diagnostic for the recurrence of HSP because its abundance is higher than primary HSP.
Conclusion: Gut microbiota can be utilized to assess the severity, recurrence, and site of HSP infection by analyzing the diversity, richness, and abundance of specific microorganisms associated with the condition.
Keywords: Gut microbiota; Henoch–Schönlein nephritis; Henoch–Schönlein purpura.
© 2025. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests. Ethical approval: Not applicable. Consent to participate: Not applicable. Consent for publication: Not applicable.
Comment in
-
Methodological considerations in gut microbiota research on IgA vasculitis: terminology, data presentation, and evidence limitations.Int Urol Nephrol. 2025 Aug 20. doi: 10.1007/s11255-025-04753-2. Online ahead of print. Int Urol Nephrol. 2025. PMID: 40833490 No abstract available.
References
References:
-
- Jennette JC et al (2013) 2012 Revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65(1):1–11 - PubMed
-
- Saulsbury FT (2010) Henoch-Schönlein purpura. Curr Opin Rheumatol 22(5):598–602 - PubMed
-
- Piram M et al (2017) Incidence of IgA vasculitis in children estimated by four-source capture-recapture analysis: a population-based study. Rheumatology (Oxford) 56(8):1358–1366 - PubMed
-
- Delbet JD et al (2017) Clinical outcomes in children with Henoch-Schönlein purpura nephritis without crescents. Pediatr Nephrol 32:1193–1199 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous